David Chan

497 total citations
23 papers, 377 citations indexed

About

David Chan is a scholar working on Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Chan has authored 23 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Epidemiology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Chan's work include Neuroendocrine Tumor Research Advances (8 papers), Medical Imaging Techniques and Applications (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). David Chan is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Medical Imaging Techniques and Applications (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). David Chan collaborates with scholars based in Australia, United States and Canada. David Chan's co-authors include Nick Pavlakis, Stephen Clarke, Joseph Chan, Alexander Engel, Anthony J. Gill, Connie I. Diakos, Dale L. Bailey, Kathy Willowson, Jason Kaplan and Jayesh Desai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgery.

In The Last Decade

David Chan

22 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Chan Australia 7 287 107 90 82 49 23 377
Fatih Teker Türkiye 7 265 0.9× 99 0.9× 83 0.9× 61 0.7× 34 0.7× 21 312
Quoc Riccardo Bao Italy 11 306 1.1× 82 0.8× 160 1.8× 109 1.3× 60 1.2× 34 399
Guochen Duan China 9 234 0.8× 81 0.8× 64 0.7× 93 1.1× 35 0.7× 30 323
Suna Çokmert Türkiye 10 218 0.8× 48 0.4× 49 0.5× 70 0.9× 44 0.9× 30 291
Alper Can Türkiye 12 228 0.8× 60 0.6× 53 0.6× 146 1.8× 39 0.8× 29 338
Michal Sarfaty Israel 13 290 1.0× 116 1.1× 149 1.7× 182 2.2× 39 0.8× 46 539
Ömer Fatih Ölmez Türkiye 9 161 0.6× 48 0.4× 48 0.5× 56 0.7× 46 0.9× 52 284
Chi‐Chung Tong China 13 271 0.9× 105 1.0× 230 2.6× 136 1.7× 34 0.7× 31 590
Xun Yang China 14 377 1.3× 99 0.9× 274 3.0× 178 2.2× 61 1.2× 47 574
Ina Nordman Australia 6 259 0.9× 69 0.6× 30 0.3× 110 1.3× 49 1.0× 18 359

Countries citing papers authored by David Chan

Since Specialization
Citations

This map shows the geographic impact of David Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chan more than expected).

Fields of papers citing papers by David Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chan. The network helps show where David Chan may publish in the future.

Co-authorship network of co-authors of David Chan

This figure shows the co-authorship network connecting the top 25 collaborators of David Chan. A scholar is included among the top collaborators of David Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chan. David Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, David, Aimee R. Hayes, Ioannis Karfis, et al.. (2025). [18F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study. Journal of Nuclear Medicine. 66(7). jnumed.124.269031–jnumed.124.269031.
2.
Loree, Jonathan M., David Chan, Jonathan Koea, et al.. (2024). Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs. JAMA Oncology. 10(12). 1707–1707. 2 indexed citations
3.
Chantrill, Lorraine A., David Ransom, David Chan, et al.. (2024). NABNEC: A randomised phase II study of nab -paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas (GI-NECs).. Journal of Clinical Oncology. 42(3_suppl). 589–589. 2 indexed citations
4.
Chou, Angela, Stephen Clarke, David Chan, et al.. (2024). Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients. European Journal of Clinical Investigation. 55(2). e14341–e14341. 1 indexed citations
5.
Chan, David, Jason Kaplan, Gary Gordon, & Jayesh Desai. (2021). Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult Cases. Current Oncology. 28(5). 3659–3667. 14 indexed citations
6.
Chan, David, James C. Yao, Carlo Carnaghi, et al.. (2021). Markers of Systemic Inflammation in Neuroendocrine Tumors. Pancreas. 50(2). 130–137. 7 indexed citations
7.
Willowson, Kathy, Geoffrey Schembri, Elizabeth J. Bernard, David Chan, & Dale L. Bailey. (2020). Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [99mTc]TcMebrofenin. European Journal of Nuclear Medicine and Molecular Imaging. 47(4). 838–848. 8 indexed citations
8.
Chan, David, Edward Hsiao, Geoffrey Schembri, et al.. (2018). FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes – A pilot study. Journal of Clinical Neuroscience. 58. 130–135. 3 indexed citations
9.
Chan, David, Geoffrey Schembri, David Brazier, et al.. (2017). Utilizing 18F‐fluoroethyl‐l‐tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI. Journal of Medical Imaging and Radiation Oncology. 62(1). 122–127. 6 indexed citations
10.
Chan, Joseph, David Chan, Connie I. Diakos, et al.. (2016). The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Annals of Surgery. 265(3). 539–546. 248 indexed citations
11.
Kanthan, Gowri L., et al.. (2016). 68Ga-DOTATATE Breast Uptake and Expression in Breast Milk. Clinical Nuclear Medicine. 41(8). 654–655. 2 indexed citations
12.
Bailey, Dale L., et al.. (2016). In Vivo Measurement and Characterization of a Novel Formulation of [177Lu]-DOTA-Octreotate.. SHILAP Revista de lepidopterología. 4(1). 30–37. 3 indexed citations
13.
Chan, David, Dale L. Bailey, Geoffrey Schembri, et al.. (2016). Dual 18F-fluorodeoxyglucose/68Gallium DOTATATE (FDG/DOTA) PET grading and histological grade in neuroendocrine tumours (NET). Figshare. 57. 157–157. 1 indexed citations
14.
Chan, Joseph, Connie I. Diakos, David Chan, et al.. (2016). Change in inflammatory status as a prognostic marker of overall survival in colorectal patients undergoing resection.. Journal of Clinical Oncology. 34(15_suppl). 6571–6571. 1 indexed citations
15.
Pearson, A. Scott, Connie I. Diakos, David Chan, et al.. (2016). Prognostic utility of tumour infiltrating lymphocytes (TILs) and neutrophil-to-lymphocyte ratio (NLR) in early-stage triple negative breast cancer (TNBC).. Journal of Clinical Oncology. 34(15_suppl). 1075–1075. 2 indexed citations
16.
Bailey, Dale L., et al.. (2015). In vivo quantification of 177Lu with planar whole-body and SPECT/CT gamma camera imaging. EJNMMI Physics. 2(1). 20–20. 18 indexed citations
17.
Bailey, Dale L., Kathy Willowson, Elizabeth J. Bernard, et al.. (2015). Preliminary direct evidence of a dose-response relationship for [Y-90]-microsphere selective internal radionuclide therapy (SIRT) in hepatic malignancy.. Journal of Clinical Oncology. 33(15_suppl). 11064–11064. 1 indexed citations
18.
Chan, David, Nick Pavlakis, Timothy Price, et al.. (2014). Impact of chemotherapy partner on efficacy of targeted therapy in metastatic colorectal cancer (mCRC): A meta-analysis.. Journal of Clinical Oncology. 32(15_suppl). 3552–3552. 5 indexed citations
19.
Li, Bob T., A. Scott Pearson, Nick Pavlakis, et al.. (2014). Malignant Cardiac Tamponade from Non-Small Cell Lung Cancer: Case Series from the Era of Molecular Targeted Therapy. Journal of Clinical Medicine. 4(1). 75–84. 10 indexed citations
20.
Chan, David, et al.. (2011). A Very Unusual Presentation of Metastatic Colon Cancer. ISRN Oncology. 2011. 1–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatih Teker Breakdown of academic impact, for papers by Quoc Riccardo Bao Breakdown of academic impact, for papers by Guochen Duan Breakdown of academic impact, for papers by Suna Çokmert Breakdown of academic impact, for papers by Alper Can Breakdown of academic impact, for papers by Michal Sarfaty Breakdown of academic impact, for papers by Ömer Fatih Ölmez Breakdown of academic impact, for papers by Chi‐Chung Tong Breakdown of academic impact, for papers by Xun Yang Breakdown of academic impact, for papers by Ina Nordman
Rankless by CCL
2026